A new hydrogen-bonded 3-D supramolecular architecture [Ni(2,2′-bpy)3]1.5[AsWVI 10WV 2O40Ni(2,2′-bpy)2(H2O)]·0.5H2O (2,2′-bpy = 2,2′-bipyridine) (1) has been hydrothermally synthesized and characterized by single-crystal X-ray diffraction analysis, PXRD, elemental analysis, XPS, and IR spectrum. Compound 1 exhibits photocatalytic activity for methylene blue degradation under visible-light irradiation and shows good stability toward visible-light photocatalysis. Luminescence of 1 is also reported.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: